Amendment

An addition or change to an IND, NDA (New Drug application), BLA (Biological License Application), PMA (pre-market approval) or PMA supplement still under review; includes safety updates.

Solutions you may be interested in

Vigilances

Comprehensive global vigilance solutions from pre-market safety to post-market surveillance

Registration & Post-approval Stage

Navigating pharmaceutical and biotechnology product registration and post-approval with expertise

Lifecycle Management

We ensure seamless compliance, manage regulatory changes, and mitigate risks—helping you maintain market access and unlock new opportunities for growth

Diverse team of professionals smiling, representing expert support at VCLS.

Questions? Get the answers from our expert team

No two product development paths are the same. Talk to our experts about your development challenges and we will provide you actionable recommendations.

Contact Us

Amendment

Amendment

RELATED INSIGHTS

How to Ensure Safety and Efficacy in Medical Device Vigilance via Patient Engagement

Ask the Experts: QPPV – What is it?

Ask the Experts: Navigating FDA & EMA CMC Expectations for Cell and Gene Therapy Product Development

Solutions you may be interested in

Vigilances

Registration & Post-approval Stage

Lifecycle Management

Questions? Get the answers from our expert team